Proteomics

Dataset Information

0

KRAS G12V digestion by 20S proteasome

ABSTRACT: KRAS is a well known tumor associated antigen. It’s a GTPase that functions as molecular switch in regulatory pathways responsible for proliferation and survival. It’s frequently mutated in a variety of cancers. One of the possible driver mutations is G12V substitution, which impairs KRAS GTPase activity and renders the mutants persistently in the GTP-bound active form, thereby promoting tumorigenesis and tumor malignancy. Its high frequency in cancers makes KRAS an attractive target for immunotherapy. We performed in vitro digestions of synthetic polypeptide corresponding to KRAS2-35 carrying the mutation with purified 20S proteasome. Samples were measured by LC-MS/MS.

INSTRUMENT(S): Orbitrap Fusion Lumos, Q Exactive

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Artem Mansurkhodzhaev  

LAB HEAD: Juliane Liepe

PROVIDER: PXD015580 | Pride | 2019-10-24

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
Description_of_the_uploaded_files_20191024.csv Csv
Description_of_the_uploaded_files_20191024.xlsx Xlsx
F011920.csv Csv
F011921.csv Csv
F011929.csv Csv
Items per page:
1 - 5 of 58
altmetric image

Publications

An <i>in silico-in vitro</i> Pipeline Identifying an HLA-A<sup>*</sup>02:01<sup>+</sup> KRAS G12V<sup>+</sup> Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients.

Mishto Michele M   Mansurkhodzhaev Artem A   Ying Ge G   Bitra Aruna A   Cordfunke Robert A RA   Henze Sarah S   Paul Debdas D   Sidney John J   Urlaub Henning H   Neefjes Jacques J   Sette Alessandro A   Zajonc Dirk M DM   Liepe Juliane J  

Frontiers in immunology 20191115

Targeting CD8<sup>+</sup> T cells to recurrent tumor-specific mutations can profoundly contribute to cancer treatment. Some of these mutations are potential tumor antigens although they can be displayed by non-spliced epitopes only in a few patients, because of the low affinity of the mutated non-spliced peptides for the predominant HLA class I alleles. Here, we describe a pipeline that uses the large sequence variety of proteasome-generated spliced peptides and identifies spliced epitope candid  ...[more]

Similar Datasets

Proteomics KRAS G12V spliced neoepitope is produced by proteasomes
2022-09-05 | PXD024528 | Pride
Proteomics Elucidation of the Signatures of Proteasome-Catalyzed Peptide Splicing
2021-05-17 | PXD025893 | Pride
Proteomics Database search engines and target database features impinge upon the identification of post-translationally cis-spliced peptides in HLA class I immunopeptidomes
2022-04-06 | PXD031709 | Pride
Proteomics Elucidation of the signatures of proteasome-catalysed peptide splicing
2020-10-26 | PXD021339 | Pride
Proteomics Identify Yeast Proteasome Cross-links with Multiple Ion Fragmentation Methods
2020-06-18 | PXD018310 | Pride
Proteomics Analysis of the fragments from hTau degraded by proteasome 20s using mass spectrometry
2020-04-22 | PXD015349 | Pride
Proteomics Mutations in epitope flanking regions for SARS-CoV-2 nucleoprotein affect proteasomal processing to alter CD8+ T cell responses
2023-10-24 | PXD032054 | Pride
Proteomics Large-Scale Immuno-Peptidome Analysis Reveals Recurrent Post-Translational Splicing of Cancer and Immune-Associated Genes
2023-05-10 | PXD034788 | Pride
Transcriptomics RNA-Seq of human AML cell line, HL-60 and its mitoxantrone resistant subline HL60/MX2
2021-01-01 | E-MTAB-8981 | biostudies-arrayexpress
Proteomics iBench Ground Truth Validation Tool 2.0
2023-12-21 | PXD044451 | Pride